Insider Transactions in Q2 2024 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,340
-0.8%
|
$23,400
$10.57 P/Share
|
|
Jun 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.96%
|
$109,450
$10.8 P/Share
|
|
Jun 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-2.34%
|
$109,450
$10.8 P/Share
|
|
Jun 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-1.43%
|
$30,870
$10.8 P/Share
|
|
Jun 20
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,129
-0.73%
|
$21,290
$10.8 P/Share
|
|
May 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,341
-0.79%
|
$23,410
$10.83 P/Share
|
|
May 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.95%
|
$120,395
$11.37 P/Share
|
|
May 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,363
-0.63%
|
$14,993
$11.37 P/Share
|
|
May 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,003
-3.31%
|
$176,033
$11.37 P/Share
|
|
Apr 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,340
-0.79%
|
$25,740
$11.03 P/Share
|
|
Apr 24
2024
|
Epperly Melissa B, |
SELL
Payment of exercise price or tax liability
|
Direct |
123
-0.54%
|
$1,230
$10.9 P/Share
|
|
Apr 24
2024
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,146
+4.81%
|
-
|
|
Apr 24
2024
|
Ilan Oren |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-0.07%
|
$540
$10.9 P/Share
|
|
Apr 24
2024
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,121
+2.57%
|
-
|
|
Apr 24
2024
|
James C Momtazee |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-0.38%
|
$2,930
$10.9 P/Share
|
|
Apr 24
2024
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,490
+1.88%
|
-
|
|
Apr 24
2024
|
Meghan Fitzgerald |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-0.6%
|
$830
$10.9 P/Share
|
|
Apr 24
2024
|
Meghan Fitzgerald |
BUY
Grant, award, or other acquisition
|
Direct |
1,261
+8.29%
|
-
|
|
Apr 22
2024
|
Richard Pulik CFO |
BUY
Grant, award, or other acquisition
|
Direct |
38,685
+11.51%
|
-
|
|
Apr 22
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Grant, award, or other acquisition
|
Direct |
38,685
-15.16%
|
-
|
|
Apr 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,002
-3.2%
|
$160,020
$10.46 P/Share
|
|
Apr 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,881
-5.26%
|
$98,810
$10.46 P/Share
|
|
Apr 20
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,515
-3.19%
|
$85,150
$10.46 P/Share
|
|
Apr 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.94%
|
$109,450
$10.46 P/Share
|